The M650K mutation decreases the firing rate of DRG neurons. by Andreas M. Kist (3106548)

Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B). by Tra-My Duong-Nu (7300970)

Procedure for detecting tobamovirus in tomato and pepper seeds decreases the cost analysis by João Eduardo Melo Almeida (5887022)

Procedure for detecting tobamovirus in tomato and pepper seeds decreases the cost analysis by João Eduardo Melo Almeida (5887022)

Mitochondrial enzyme ALAS1 interacts with MeV-V protein. by Pierre Khalfi (7868252)

Subjects:

Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”

Relative <i>APOBEC3A</i> and MeV <i>M</i> mRNA quantification upon MeV infections in cells stably expressing DNase I. by Pierre Khalfi (7868252)

Subjects:

Depletion of endogenous SRF or Elk-1 decreases DUSP5 mRNA induction by serum stimulation. by Camille Buffet (839290)

A summary of the included study characteristics. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

Absence of adaptive immunity decreases tumor cell damage in MDR1A deficiency. by Eva Maria Hennenberg (4234018)

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…</p>Results<p>In a dose-dependent manner, ruxolitinib addition synergizes with UCB-Tregs to suppress SLE-PBMC proliferation, inhibit CD8⁺ T cells, and reduce phosphorylation of STAT3/STAT5/AKT in CD8⁺ T cells. …”

Rab27A deficiency caused decreased amylase release from isolated acini. by Yanan Hou (736195)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC₅₀ = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …”

Tumor-antigen-specific CD8⁺ T cell proliferation in draining lymph nodes decreases with increasing tumor burden. by Joanne K. Gardner (725995)

Decrease of cell viability and alterations of cell membrane permeability by infection with rotavirus isolates. by Carlos A. Guerrero (1264551)

Average trap captures for infected and uninfected <i>Ae</i>. <i>aegypti</i>. by Tom L. Schmidt (4053622)

“…<p><i>Ae</i>. <i>aegypti</i> caught offsite (A) and onsite (B) are graphed atop weekly Cairns rainfall. …”

Netrin-1 overexpression increases HCV RNA and specific infectivity of HCV virions in vitro whereas Netrin-1 depletion decreases HCV RNA and specific infectivity in vitro. by Marie-Laure Plissonnier (337713)

“…Netrin-1 depletion impedes HCV. Huh7.5 cells were transfected with siRNAs, infected at a MOI of 0.1 24 h after seeding, and trypsinized at day five post-infection before a second siRNA transfection. …”

Archazolid decreases the activity and expression of cathepsin B in endothelial cells. by Betty Luong (5738027)

Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

“…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”

Relative decreases in VP mean weights using -DDE against TP controls in nine laboratories (Lab) by William Owens (20777)